EUVIMEDEUVIMED entdecken
Open Access

Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits

Mandana Chitsazan, Juhi K Parekh, Amanda L Grundmann iD, Emily S Lau, Mona Alotaibi, Bing Yu, Casey M Rebholz, Elizabeth Selvin iD, Norrina B Allen, Matthew A Allison, Mohit Jain, Susan Cheng und 1 weitere

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Mandana Chitsazan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Obesity, Eicosanoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The molecular pathways by which obesity contributes to systemic inflammation are unclear. Eicosanoids are bioactive lipids that govern the upstream initiation of pro‐ and anti‐inflammatory activity. We sought to investigate the association of eicosanoids with obesity, adiposity, and cardiometabolic traits.

Methods

We conducted a cross‐sectional analysis of the Multi‐Ethnic Study of Atherosclerosis (MESA) study with external validation in two community‐based cohorts: Framingham Heart Study and Atherosclerosis Risk in Communities Study. We measured 811 eicosanoids using a directed, non‐targeted mass spectrometry‐based platform and examined their associations with BMI and eight related adiposity and cardiometabolic traits using multivariable‐adjusted linear regression.

Results

Among 5101 MESA participants (mean age 63 years, 53% women), we found 255 eicosanoids and related metabolites associated with BMI (FDR q < 0.01 for all). Among these, 82 showed consistent associations across all three cohorts, including 18 metabolites with known identities: 9 were associated with lower BMI including docosahexaenoic acid derivative 19,20‐DiHDPA, arachidonic acid derivatives (20‐carboxy‐arachidonic acid, 5,6‐diHETrE, 14,15‐diHETrE, 15‐HpETE), and eicosapentaenoic acid derivative 5‐HpEPE. By contrast, 9 metabolites associated with higher BMI including hydroxyoctadecenoic acid (HOME), 11‐hydroxy‐9‐octadecenoic acid (11‐HOME), and adrenic acid. Many BMI‐associated metabolites overlapped with other adipose traits including 240 (94%) with waist circumference and 93 (36%) with visceral adipose tissue.

Conclusion

We identified 82 BMI‐associated eicosanoids, including docosanoids and arachidonic acid derivatives associated with lower BMI, while octadecanoids and adrenic acid derivatives were associated with higher BMI. Our findings highlight the role of bioactive lipids and specific pro‐ and anti‐inflammatory pathways that may underlie adverse cardiometabolic consequences of obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityEicosanoidsHumansFemaleCross-Sectional StudiesMiddle AgedMaleBody Mass IndexAgedAdiposityInflammationCardiometabolic Risk Factors

Stichwörter der Autor:innen

eicosanoidsinflammationobesity

Substanzen

Eicosanoids

Autor:innen und Institutionen

  • Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • CardioVascular Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Universitätsmedizin-Charité, Berlin, Germany.
  • Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Amanda L Grundmann, Elizabeth Selvin

Förderung

  • The National Heart, Lung, and Blood Institute (NHLBI)
  • NHLBI NIH HHS
  • American Heart Association
  • Deutscher Akademischer Austauschdienst
  • Foundation for the National Institutes of Health
  • NCATS NIH HHS
  • NIEHS NIH HHS
  • Deutsche Herzstiftung

Zitieren

APA

Chitsazan, M., Parekh, J. K., Grundmann, A. L., Lau, E. S., Alotaibi, M., Yu, B., Rebholz, C. M., Selvin, E., Allen, N. B., Allison, M. A., Jain, M., Cheng, S., & Ho, J. E. (2026). Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71269

Vancouver

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, et al. Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71269

BibTeX
@article{Chitsazan2026,
  author = {Chitsazan, Mandana and Parekh, Juhi K and Grundmann, Amanda L and Lau, Emily S and Alotaibi, Mona and Yu, Bing and Rebholz, Casey M and Selvin, Elizabeth and Allen, Norrina B and Allison, Matthew A and Jain, Mohit and Cheng, Susan and Ho, Jennifer E},
  title = {Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71269}
}
Kostenlos starten →